Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-07-11 00:00:00 ET · period of report 2023-07-10 · accession 0001562180-23-005845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-07-11 | 2023-07-10 | SNDX | Morrison Briggs | Dir | S - Sale+OE | $20.40 | -52.9K | 17.8K | -75% | -$1.08M |
| DT | 2023-07-11 | 2023-07-10 | SNDX | Morrison Briggs | Dir | M - OptEx | $8.77 | +52.9K | 70.7K | +296% | +$463.5K |
| DT | 2023-07-11 | 2023-07-10 | SNDX | Morrison Briggs | Dir | M - OptEx | $0.00 | -52.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-10 | S | D | 52,855 | $20.40 | 17,836 | D | — | — | (F2) The sale prices ranged from $20.11 to $20.71. |
| 2 | Common | Common Stock | 2023-07-10 | M | A | 52,855 | $8.77 | 70,691 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2023-07-10 | M | D | 52,855 | $0.00 | 0 | D | $8.77 · — to 2027-02-06 | 52,855 Common Stock | (F3) This option is fully vested. |